• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
FDA
 
FDA Presentations for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee (PDF – 195KB)
 
 
Biomedical Advanced Research and Development Authority (BARDA)
 
BARDA Presentation for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee (PDF – 8.90MB)
 
 
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
 
NIAID Presentations for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee (PDF – 1.77MB)
 
Amgen, Inc.
 
Amgen Presentations for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee (PDF – 716KB)
 
Genzyme Corporation, a Sanofi Company
 
Genzyme Presentations for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee (PDF – 901KB)
 
Teva Branded Pharmaceutical Products R&D, Inc.
 
Teva Presentation for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee (PDF – 628KB)
 
 
Guest Speaker
 
Nicholas Dainiak, M.D. Presentation for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee (PDF – 1.29MB)